Trial
NCT05322954
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Wisconsin, Madison
Collaborators
Revive Therapeutics, Ltd.
Condition
Methamphetamine Use Disorder
Intervention
Psilocybin
Why stopped
due to sponsor financial constraints
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-12